Scope Health recalls Optase Dry Eye Intense Drops (Glycerin 0.2%)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Optase Dry Eye Intense Drops (Glycerin 0.2%)
- Company
- Scope Health
- Where it was sold
-
Nationwide within the United States
Nationwide
- About this recall
- Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.